Sichuan Huiyu Pharmaceutical Co., Ltd. (SHA:688553)

China flag China · Delayed Price · Currency is CNY
18.49
+0.75 (4.23%)
Mar 10, 2026, 3:00 PM CST
12.81%
Market Cap 7.79B
Revenue (ttm) 998.15M
Net Income (ttm) -24.20M
Shares Out 421.46M
EPS (ttm) -0.06
PE Ratio n/a
Forward PE n/a
Dividend 0.46 (2.61%)
Ex-Dividend Date Jun 13, 2025
Volume 3,781,207
Average Volume 3,630,766
Open 17.99
Previous Close 17.74
Day's Range 17.99 - 18.54
52-Week Range 13.02 - 28.28
Beta 0.39
RSI 44.77
Earnings Date Apr 25, 2026

About SHA:688553

Sichuan Huiyu Pharmaceutical Co., Ltd. research and develops, produces, and sells anti-tumor injection in China and internationally. The company offers injection drug products, such as pemetrexed disodium, methrotraxate, docetaxel, azacitidine, oxaliplatin, cyclophosphamide, irinotecan hydrochloride, paclitaxel, bendamustine hydrochloride, decitabine, palonosetron hydrochloride, plerixafor, levetiracetam concentrated solution, amifostine, levofolate calcium, thiotepa, fulvestrant, and milrinone drugs. It also offers moroxydine sodium chloride, ... [Read more]

Sector Healthcare
Founded 2010
Employees 1,331
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688553
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.